Wacker Chemie AG Financial Results FY 2025 | Restructuring, Cost Cuts & Recovery Outlook

Wacker Chemie AG FY 2025: Key TakeawaysPresented by Joerg Hoffmann, Head of Investor RelationsWacker Chemie AG presented its full year 2025 financial results, with Joerg Hoffmann, Head of Investor Relations, guiding investors through a difficult but strategically important reporting period that may mark the turning point in the company’s current earnings cycle.The FY 2025 presentation is significant because it combines two elements that investors care deeply about in cyclical industrial and chemical names: first, a clear acknowledgment of operational weakness, and second, a decisive strategic response. WACKER’s results show that 2025 was one of the most challenging years in recent memory, as weak demand, pricing pressure, elevated energy costs in Germany, and continued overcapacity in key chemical markets weighed on earnings across multiple divisions. Public reports around the annual release indicate that group sales declined 4% to €5.49 billion, reported EBITDA fell 43% to €427 million, and the company posted a net loss of €805 million.FY 2025 as a Reset Year Rather Than Just a Weak YearAt first glance, those numbers are clearly weak. But the deeper capital-markets message is more nuanced. FY 2025 appears to be a reset year rather than simply a bad year. The company also reported EBITDA before special effects of €529 million, suggesting that while the underlying business was under pressure, the reported figures were further impacted by restructuring charges and other non-recurring items tied to strategic action.PACE: The Largest Cost-Saving Initiative in WACKER’s HistoryThat strategic action is the centerpiece of the presentation: the launch of PACE, the largest cost-saving initiative in WACKER’s history. The program targets more than €300 million in annual savings by 2027–2028 and includes major reductions in fixed production and administrative costs, as well as more than 1,500 job cuts.This is a major signal to investors that management is not waiting for the cycle to improve on its own. Instead, WACKER is actively resizing its cost base to rebuild profitability and improve competitiveness.Segment Performance: Broad-Based Pressure Across the PortfolioFrom a segment perspective, the results show that pressure was broad-based. Silicones remained the largest division and held up comparatively better, with only a modest EBITDA decline despite weaker market conditions.Polymers suffered from continued softness in construction-related demand, while Biosolutions remained strategically interesting but too small to offset broader weakness.Polysilicon, one of the most closely watched businesses, experienced a sharp earnings decline as margin pressure intensified in a volatile market environment. This broad-based weakness is important because it explains why the group could not rely on diversification alone to protect earnings in 2025.From Cyclical Exposure to Active Turnaround StoryFor investors, the most important takeaway is that WACKER is now shifting from a passive cyclical story to a more active turnaround and self-help story. The company is not only waiting for better end-market demand in silicones, polymers, and polysilicon. Read more on: https://seat11a.com/company/wacker-chemie-ag-financial-results-fy-2025/ ▶️ Other videos:Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/Company Presentation: https://seat11a.com/investor-relations-company-presentation/Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/ESG Presentation: https://seat11a.com/investor-relations-esg/T&CThis publication is for informational purposes only and does not constitute investment advice. Using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.